BusinessWire China - 所有的文章 - 共有 13346 篇文章 搜尋時間 0.018 秒
Prestige BioPharma』s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
2022-02-21 15:37:00 by BusinessWire China @ BusinessWire China [引用來源]
SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Limited (950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, announced that the manufacturing facility for i...... [閱讀更多]
腦再生科技有限公司的EARTH有效性試驗顯示，其試驗中RGC-COV19™ 液體方劑可以在6天療程中有效清除入組患者的COVID-19輕至中度症狀 - 美國商業資訊
2022-02-21 14:16:00 by BusinessWire China @ BusinessWire China [引用來源]
香港--(美國商業資訊)--腦再生科技有限公司 (NASDAQ: RGC)（ 「 腦再生 」 或 「 公司」）今天發表了由腦再生科技(亞洲)有限公司 (「腦再生(亞洲)」) 展開的新型COVID-19口服候選中藥RGC-COV19 TM（Regencell Asia (RGCA-CV01)液體製劑）有效性試驗的分析結果。該試驗名為 Evaluation and Assessment ...... [閱讀更多]
藍洞新消費就英美煙草2021年初步業績發表產業評論 - 美國商業資訊
2022-02-21 11:46:00 by BusinessWire China @ BusinessWire China [引用來源]
中國深圳--(美國商業資訊)--中國首屈一指的電子煙媒體藍洞新消費(Bluehole New Consumption)今天就英美煙草(BAT) 2021年初步業績發表產業評論。 此新聞稿包含多媒體內容。完整新聞稿可在以下網址查閱：https://www.businesswire.com/news/home/20220217005051/en/ 以下是該報導的繁體中文翻譯版...... [閱讀更多]
Nipa Cloud Selects Juniper Networks to Help Accelerate Digital Transformation Across Thailand』s Enterprises
2022-02-21 11:03:00 by BusinessWire China @ BusinessWire China [引用來源]
BANGKOK--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Nipa Cloud (Nipa), a leading cloud services provider in Thai...... [閱讀更多]
Quanergy物聯網應用感測器訂貨量破1,000大關 - 美國商業資訊
2022-02-21 09:26:00 by BusinessWire China @ BusinessWire China [引用來源]
加州森尼韋爾--(美國商業資訊)--為汽車和物聯網產業提供採用光學相位陣列(OPA)技術的固態雷射雷達(LiDAR)感測器和智慧3D解決方案的領導廠商Quanergy Systems, Inc.（NYSE: QNGY和QNGY.WS）今天宣布，2021年第四季該公司廣泛物聯網應用的感測器訂貨數量突破1,000大關。 此新聞稿包含多媒體內容。完整新聞稿可在以下網址查閱：https...... [閱讀更多]
Puzzle & Dragons 10週年紀念作品PUZZLE & DRAGONS Nintendo Switch Edition好評暢銷中！
2022-02-21 09:20:00 by BusinessWire China @ BusinessWire China [引用來源]
東京--(BUSINESS WIRE)--(美國商業資訊)--GungHo Online Entertainment, Inc. (TOKYO:3765) 已於2022年2月20日（日）推出Nintendo Switch™用軟體PUZZLE & DRAGONS Nintendo Switch Edition（https://pad-switch.com/en/），本作是智慧型...... [閱讀更多]
European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
2022-02-21 09:17:00 by BusinessWire China @ BusinessWire China [引用來源]
DARMSTADT, Germany -- (BUSINESS WIRE) -- Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib)...... [閱讀更多]
XPeng to be Added to The Hang Seng TECH Index as a Constituent Stock
2022-02-21 09:13:00 by BusinessWire China @ BusinessWire China [引用來源]
GUANGZHOU, China--(BUSINESS WIRE)--XPeng Inc. (「XPeng」 or the 「Company,」 NYSE: XPEV, HKEX: 9868), a leading Chinese smart electric vehicle (「Smart EV」) company, is pleased to announce that it w...... [閱讀更多]
Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
2022-02-21 09:07:00 by BusinessWire China @ BusinessWire China [引用來源]
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the results of an exploratory analysis from the Phase III JAVELIN Bladder 100 trial with 19...... [閱讀更多]
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2
2022-02-21 08:54:00 by BusinessWire China @ BusinessWire China [引用來源]
OSAKA, Japan & CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical r...... [閱讀更多]
